Published

[Treatment with psychedelics: potential benefits in Parkinson's disease].

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Revue medicale suisse
Date: 2025-04-23
Source: PubMed
DOI: 10.53738/revmed.2025.21.915.47180
PubMed: 40275842

Authors

Penzenstadler L Baudois S Lingenberg A Catalano Chiuvé S Tomkova E Fleury V

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Addiction OCD Neuroplasticity Receptor Pharmacology Clinical Trial Safety Inflammation Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.Medical hypotheses · 2020-01-01